|
⚲
|
| Keyboard |
| Cuddihy Robert V Jr
✚
|
|
|---|---|
| CIK # | 0001142043 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001142043] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cuddihy Robert V Jr | |
| ProPhase Labs Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ProPhase Labs Inc PRPH
Common Stock, par value $0.005
|
2017-09-29 | Sell | 358,621 | $2.30 | 824,828 |
|
ProPhase Labs Inc PRPH
Common Stock, par value $0.005
|
2017-09-14 | Option exercise | 120,000 | $1.65 | 198,000 |
|
ProPhase Labs Inc PRPH
Employee Stock Option (right to buy) · derivative
|
2017-09-14 | Option exercise | 200,000 | $0.00 | |
|
ProPhase Labs Inc PRPH
Employee Stock Option (right to buy) · derivative
|
2017-09-14 | Option exercise | 120,000 | $0.00 | |
|
ProPhase Labs Inc PRPH
Employee Stock Option (right to buy) · derivative
|
2017-09-14 | Option exercise | 40,000 | $0.00 | |
|
ProPhase Labs Inc PRPH
Common Stock, par value $0.005
|
2017-09-14 | Option exercise | 40,000 | $1.39 | 55,600 |
|
ProPhase Labs Inc PRPH
Common Stock, par value $0.005
|
2017-09-14 | Option exercise | 200,000 | $1.00 | 200,000 |
|
ProPhase Labs Inc PRPH
Option (right to buy) · derivative
|
2014-12-20 | Grant | 40,000 | $0.00 | |
|
ProPhase Labs Inc PRPH
Option (right to buy) · derivative
|
2013-12-19 | Grant | 120,000 | $0.00 | |
|
ProPhase Labs Inc PRPH
Common Stock, par value $0.0005
|
2012-01-11 | Grant | 10,757 | $0.00 |